Call Today

Workshop: Manifestation of Microvascular Dysfunction in a Rat Model of Diabetic Cardiomyopathy: Teasing Apart Sex-Dependent Differences with Multimodality Imaging

Workshop: Manifestation of Microvascular Dysfunction in a Rat Model of Diabetic Cardiomyopathy: Teasing Apart Sex-Dependent Differences with Multimodality Imaging

Scintica will be at the American Physiological Summit 2024 (APS 2024) in Long Beach, CA – we will be at booth 139! We also invite you to visit us at the Innovation Stage on April 6th from 10:15am – 11am for our workshop by speaker, Sadi Loai, while he presents his work titled: Manifestation of Microvascular Dysfunction in a Rat Model of Diabetic Cardiomyopathy: Teasing Apart Sex-Dependent Differences with Multimodality Imaging.

WHEN: April 6, 2024 @ 10:15am – 11am
WHERE: Long Beach Convention Center, Innovation Stage
SPEAKER: Sadi Loai, PhD (Product Specialist, Scintica)
.
OVERVIEW:
Microvascular dysfunction has been implicated as the primary hallmark of several cardiac and inflammatory diseases (e.g., diabetes, heart failure, kidney disease), affecting millions of people worldwide. The onset and progression of microvascular disease is driven by vascular inflammation and is characterized by impaired vasomodulation. The ability to noninvasively assess microvascular function is essential to assessing intact microvascular reactivity. In this session we will discuss the findings from a recent study which employed multimodality imaging (MRI, ultrasound, photoacoustic, laser Doppler) along with standardized clinical testing, with the purpose of understanding the progression of diabetic cardiomyopathy while teasing apart sex-dependent differences.

Date

Apr 06 2024
Expired!
10:15 am - 11:00 am

Speaker

  • Sadi Loai, PhD
    Sadi Loai, PhD
    Sadi Loai, PhD
    Sadi Loai, PhD

    Sadi Loai is a distinguished researcher specializing in biomedical engineering and medical imaging. He earned his PhD in Biomedical Engineering from the University of Toronto, where he focused on developing advanced imaging techniques for diabetes induced heart failure. Dr. Loai has made significant contributions to the field of preclinical imaging, particularly in the development and application of contrast agents in MRI, understanding the link between type II diabetes and HFpEF, and developing early diagnostic markers. Dr. Loai’s research has been published in several peer-reviewed journals, reflecting his commitment to advancing knowledge in biomedical imaging. He is currently affiliated with Scintica Instrumentation as a Product Manager, where he continues to drive innovation in preclinical imaging solutions.

Explore our Past Webinars